• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

Dermatology Times

Dermatology Times, November 2024 (Vol. 45. No. 11)
Volume45
Issue 11

Promoting Positive Skin Health Education

Key Takeaways

  • National Healthy Skin Month promotes skin health education, with Dermatology Times covering AI-driven psoriasis treatment and melanoma in young patients.
  • AI is used to optimize zasocitinib, a tyrosine kinase 2 inhibitor, through collaboration with Nimbus Therapeutics and Schrödinger.
SHOW MORE

Join Dermatology Times in celebrating National Healthy Skin Month.

female patient looking in mirror | Image Credit: © Rido - stock.adobe.com

Image Credit: © Rido - stock.adobe.com

November kicks off the 27th annual National Healthy Skin Month since 1997. The American Academy of Dermatology launched National Healthy Skin Month to promote skin health education and healthy habits.1 The November issue of Dermatology Times includes features on artificial intelligence for the development of a new psoriasis treatment, melanoma in young patients, addressing causes of female hair loss, benzene found in benzoyl peroxide at room temperature, and more—all to provide clinical pearls to improve patient health.

This month’s cover feature explores the use of artificial intelligence in developing zasocitinib (TAK-279; Takeda), an innovative oral allosteric tyrosine kinase 2 inhibitor. Graham Heap, MBBS, PhD; Christopher Bunick, MD, PhD; and Melinda Gooderham, MD, MSc, FRCPC, provide insights into Takeda’s collaboration with Nimbus Therapeutics and Schrödinger to allow researchers to optimize the zasocitinib design process, ensuring that the compound fits precisely into the target enzyme’s pocket.

In an expert-written review, Adam Leavitt, MD, and coauthors discuss the challenging causes of female hair loss and prevention methods. More than 50% of postmenopausal women experience frontal/parietal hair loss, as do up to 40% of healthy women, often around the beginning of reproductive age. Leavitt et al stress that the lack of FDA-approved treatments contributes to a growing demand for nonpharmaceutical therapies. The authors concluded that by considering the root causes of female hair loss, key ingredients and interventions can be identified to help women.

Dermatology Times provides readers with the most up-to-date clinical content, from innovative studies and FDA approvals to exclusive interviews and expert insights. Stay informed with the latest data by subscribing to our e-newsletters; following us on Facebook, LinkedIn, and X (formerly Twitter); and emailing us with ideas or contributions at DTEditor@mmhgroup.com.

Reference

1. November is National Healthy Skin Month. American Academy of Dermatology Association. Updated January 24, 2024. Accessed October 16, 2024. https://www.aad.org/public/public-health/awareness-campaigns/national-healthy-skin-month

Related Videos
infectious disease
© 2024 MJH Life Sciences

All rights reserved.